Role of the immune tumor microenvironment in neoadjuvant treatment response of gastro-esophageal adenocarcinoma
Luminal-basale Tumorheterogenität für die Prädiktion neuer Behandlungsmöglichkeiten in Hochrisikopatientinnen des Hormonrezeptor-positiven/HER2-negativen frühen Brustkrebs
Dissecting survivin (patho)biology by motional restriction of its flexible protein elements with dynamic supramolecular ligands
Development of novel treatment strategies based on investigations into the molecular pathobiology of adenosquamous gastric cancer
Proteolytisches Targeting von Menin/MEN1 zur Behandlung von akuter B-Zell-Lymphoblasten-Leukämie, B-Zell-Lymphom und multiplem Myelom
